TAPI-1

CAS No. 171235-71-5

TAPI-1( TAPI-1 | TNF-alpha Protease Inhibitor-1 )

Catalog No. M18119 CAS No. 171235-71-5

TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 1476 In Stock
50MG 2232 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TAPI-1
  • Note
    Research use only, not for human use.
  • Brief Description
    TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.
  • Description
    TAPI-1 is and inhibitor of TACE. It inhibits the cleavage of TNF-a, TNFRI (p60), and TNFRII (p80).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TAPI-1 | TNF-alpha Protease Inhibitor-1
  • Pathway
    GPCR/G Protein
  • Target
    GHSR
  • Recptor
    ADAM17/TACE
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    171235-71-5
  • Formula Weight
    499.6
  • Molecular Formula
    C26H37N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)CC(CC(=O)NO)C(=O)N[C@@H](Cc1cc2ccccc2cc1)C(=O)N[C@@H](C)C(=O)NCCN
  • Chemical Name
    N-[(2S)-1-[[(2S)-1-(2-Aminoethylamino)-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Müllberg J, et al. J Immunol. 1995, 155(11), 5198-5205.
molnova catalog
related products
  • Relamorelin

    Relamorelin(BIM28131, RM131) is a selective and potent ghrelin/growth hormone secretagogue receptor (GHSR) agonist with high affinity for GHS-1a receptor (Ki value is 0.42 ± 0.063 nM).

  • Livoletide

    A first-in-class analogue of unacylated ghrelin, and unacylated ghrelin receptor agonist.

  • K-(D-1-Nal)-FwLL-NH2

    High affinity and potent ghrelin receptor inverse agonist (Ki values are 4.9 and 31 nM in COS7 and HEK293T cells, respectively). Blocks ghrelin receptor-mediated Gq- and G13-dependent signaling pathways.